Overview
Title
To amend the Controlled Substances Act to require regulated persons to identify tableting machines and encapsulating machines by serial number.
ELI5 AI
H. R. 9540 wants to put special numbers on machines that make tiny pills and capsules so they can be tracked and stop bad people from using them. If someone changes or moves these numbers, they can get into big trouble.
Summary AI
H. R. 9540 seeks to update the Controlled Substances Act by requiring people who manufacture, distribute, or deal with tablet and capsule-making machines to engrave a permanent serial number on these machines. This bill, known as the “Fight Illicit Pill Presses Act of 2024,” aims to make it easier to track these machines and prevent illegal activities. It also introduces penalties for tampering with or transporting such machines if the serial numbers are altered or removed. The Attorney General has 180 days after the bill becomes law to establish supporting regulations.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
General Summary of the Bill
The bill titled "H. R. 9540", also known as the "Fight Illicit Pill Presses Act of 2024," aims to amend the Controlled Substances Act. This amendment mandates that any tableting and encapsulating machines used within the controlled substances industry be marked with a permanent serial number. This step is being taken to enhance the traceability and accountability of these machines. Moreover, the bill introduces provisions making it illegal to tamper with these serial numbers or to possess machines with altered identifiers. The Attorney General is tasked with issuing the necessary regulations to put this requirement into practice.
Summary of Significant Issues
The bill, while straightforward in its goal, encounters several potential issues. Among these is the absence of detailed information regarding budget allocation for compliance, which may lead to unexpected costs. The language specifying how serial numbers are to be affixed might allow for varied interpretations, leading to potential inconsistencies. The timeframe of 180 days for the Attorney General to develop necessary regulations may be too brief, possibly affecting the quality of the regulations. Furthermore, the bill does not adequately address the financial and operational burdens that implementation could impose on various stakeholders, notably manufacturers and distributors.
Impact on the Public
If effectively implemented, the legislation could contribute positively to public safety by making it more difficult for illicit producers to use tableting and encapsulating machines anonymously. This could decrease the production of illegal pills, potentially reducing drug-related harm within communities. However, how the serial number requirement is enforced, and its impact on legitimate users of such machines, remains a concern. Inconsistent application or understanding of the regulations could create confusion and challenges for businesses and enforcement authorities alike.
Impact on Specific Stakeholders
Manufacturers and Distributors: For those involved in the production and distribution of tableting and encapsulating machines, this bill might introduce significant responsibilities, particularly in terms of compliance costs and operational adjustments required to engrave or affix serial numbers on every machine. This could disproportionately impact smaller businesses with less capacity to absorb new regulatory expenses.
Regulators and Law Enforcement: The categorization of new criminal activities related to serial number tampering necessitates clear guidelines for enforcement. Ambiguities in the regulatory language might present challenges in enforcing the law consistently and fairly.
Healthcare and Pharmaceutical Industries: While the bill aims to curb illegal activities, legitimate players in these sectors may experience operational burdens if supply chain processes for these machines become more complex or if delays occur due to regulatory compliance.
Overall, while the bill's aim of curbing illicit pill production is commendable, the implementation details and regulatory burdens require careful consideration to avoid unintended negative consequences on legitimate stakeholders and ensure clear, enforceable guidelines.
Issues
The section regulating the implementation of serial numbers on tableting and encapsulating machines does not specify the cost or budget allocation, potentially leading to unforeseen expenses for compliance (Section 2).
The language used to describe the method of affixing serial numbers ('engraved, cast, or otherwise permanently affixed') may allow for varying interpretations and inconsistent implementation across manufacturers, which could lead to legal and regulatory challenges (Section 2).
The timeline for the Attorney General to promulgate regulations within 180 days could be insufficient for thorough development and review, especially if complexities arise during the regulatory process. This tight timeline may impact the effectiveness and clarity of the regulations (Section 2).
The bill does not address the potential financial and operational burdens on manufacturers, distributors, sellers, importers, or exporters in terms of engraving serial numbers, which could impose unequal burdens and impact smaller businesses more significantly than larger ones (Section 2).
The amendment allows for severe legal liabilities by criminalizing actions related to serial numbers (such as removal or alteration), but the definitions and practical implications of such actions are not clarified, potentially leading to unintended legal consequences (Section 2).
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the Act is titled "Short title." It states that this legislation can be officially called the “Fight Illicit Pill Presses Act of 2024.”
2. Regulation of certain machines Read Opens in new tab
Summary AI
The passage outlines amendments to the Controlled Substances Act requiring that tableting and encapsulating machines have permanently affixed serial numbers and makes it illegal to tamper with or possess machines with altered serial numbers. Additionally, new regulations will be established to enforce these changes, applying only to machines manufactured or handled after the rules are in effect.